A phase 2 trial of TAS-102 with or without celecoxib in ctDNA-defined minimal residual disease (MRD) in colorectal cancer after completion of adjuvant chemotherapy. This is an ASCO Meeting Abstract ...

Matthew Ng, MD, with The George Washington University Hospital and Cedar Hill Regional Medical Center discusses colorectal ...

A new definition of rectal cancer in the Netherlands prompted reclassification of cancer as sigmoid tumors, which could lead to better treatment. Rectal and sigmoidal tumors have been hard to ...

After decades of decline, rectal cancer is rising in all adult age groups, according to a new report from the American Cancer Society. What's extra notable is how it's impacting rates in younger ...

Deaths from rectal cancer are accelerating among people in their 30s and 40s at a clip that’s alarming researchers. Learn the red flags. Among millennials, the rectal cancer death rate is accelerating ...

Colorectal cancers are the third-leading cause of cancer-related deaths for men and fourth for women, but is the second overall when men and women are combined, according to data compiled by the ...

Deaths from rectal cancer are rising rapidly among younger adults, an alarming trend that is confounding scientists trying to understand why millennials are so hard-hit. “The rate of rectal cancer ...

Rates of rectal cancer deaths are rising in adults under 50.

Among millennials, the rectal cancer death rate is accelerating much faster than the rate from colon cancer, according to new research. A tumor in the rectum can cause bright red blood on the stool, ...